Projected Income Statement: Akzo Nobel N.V.

Forecast Balance Sheet: Akzo Nobel N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 1,034 2,398 4,089 3,785 3,901 3,718 3,422 2,999
Change - 131.91% 70.52% -7.43% 3.06% -4.69% -7.96% -12.36%
Announcement Date 2/17/21 2/9/22 2/8/23 2/7/24 1/28/25 - - -
1EUR in Million
Estimates

Cash Flow Forecast: Akzo Nobel N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 258 288 292 286 306 347.6 352.2 343.1
Change - 11.63% 1.39% -2.05% 6.99% 13.59% 1.33% -2.59%
Free Cash Flow (FCF) 1 962 317 -29 840 367 648 735.1 896
Change - -67.05% -109.15% 2,996.55% -56.31% 76.57% 13.44% 21.88%
Announcement Date 2/17/21 2/9/22 2/8/23 2/7/24 1/28/25 - - -
1EUR in Million
Estimates

Forecast Financial Ratios: Akzo Nobel N.V.

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) 16.91% 14.98% 10.67% 13.4% 13.8% 14.28% 15.11% 15.64%
EBIT Margin (%) 12.88% 11.39% 7.27% 10.07% 10.39% 10.9% 11.66% 12.2%
EBT Margin (%) 10.77% 11.53% 5.55% 7.35% 7.82% 8.28% 10.07% 11.07%
Net margin (%) 7.39% 8.65% 3.25% 4.14% 5.06% 5.51% 6.81% 7.5%
FCF margin (%) 11.28% 3.31% -0.27% 7.87% 3.43% 6.11% 6.79% 8.03%
FCF / Net Income (%) 152.7% 38.24% -8.24% 190.05% 67.71% 110.93% 99.74% 107.05%

Profitability

        
ROA 5.67% 5.57% 2.99% 3.57% 4.6% 4.45% 5.55% 6%
ROE 12.27% 13.48% 8.77% 12.09% 14.91% 13.89% 15.93% 16.32%

Financial Health

        
Leverage (Debt/EBITDA) 0.72x 1.67x 3.53x 2.65x 2.64x 2.46x 2.09x 1.72x
Debt / Free cash flow 1.07x 7.56x -141x 4.51x 10.63x 5.74x 4.66x 3.35x

Capital Intensity

        
CAPEX / Current Assets (%) 3.02% 3% 2.69% 2.68% 2.86% 3.28% 3.25% 3.08%
CAPEX / EBITDA (%) 17.89% 20.06% 25.24% 20.01% 20.7% 22.97% 21.53% 19.66%
CAPEX / FCF (%) 26.82% 90.85% -1,006.9% 34.05% 83.38% 53.64% 47.91% 38.29%

Items per share

        
Cash flow per share 1 6.374 3.27 1.505 6.6 6.249 5.602 5.982 6.636
Change - -48.69% -53.97% 338.43% -5.32% -10.35% 6.78% 10.93%
Dividend per Share 1 1.95 1.98 1.98 1.98 1.98 1.98 2.059 2.157
Change - 1.54% 0% 0% 0% -0% 4.01% 4.76%
Book Value Per Share 1 30.02 29.32 24.8 25.33 26.81 28.13 30.23 33.19
Change - -2.32% -15.42% 2.14% 5.83% 4.92% 7.46% 9.79%
EPS 1 3.32 4.46 2.01 2.59 3.17 3.54 4.517 5.134
Change - 34.34% -54.93% 28.86% 22.39% 11.69% 27.57% 13.68%
Nbr of stocks (in thousands) 192,726 182,386 177,400 170,595 170,779 170,900 170,900 170,900
Announcement Date 2/17/21 2/9/22 2/8/23 2/7/24 1/28/25 - - -
1EUR
Estimates
2025 *2026 *
P/E ratio 17.1x 13.4x
PBR 2.15x 2x
EV / Sales 1.33x 1.27x
Yield 3.28% 3.41%
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
60.42EUR
Average target price
69.78EUR
Spread / Average Target
+15.49%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. AKZA Stock
  4. Financials Akzo Nobel N.V.